Leveraging Roundtrip, the single touchpoint for medical transportation, to eliminate transportation as a barrier to care for specialized patient populations such as those with opioid use disorder.
Leveraging Roundtrip, the single touchpoint for medical transportation, to eliminate transportation as a barrier to care for specialized patient populations such as those with opioid use disorder.
利用医疗运输的单一接触点往返，消除交通作为护理特殊患者群体（例如阿片类药物使用障碍患者）的障碍。
批准号：
10013780
负责人：
Brendan McNiff
金额：
$25.21万
依托单位：
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-04-01 至 2021-03-31
关键词：
AddressAdherenceAdoptionAffectAlcohol or Other Drugs useAmbulancesAmbulatory CareAppointmentBackBehavioralBooksCaregiversCaringCharacteristicsClientClinicalCommunitiesComputer softwareCountryDataData CollectionDrug AddictionDrug Metabolic DetoxicationDrug usageEducationEmergency department visitEnrollmentFeedbackFinancial HardshipGoalsGrantHealthHealth ExpendituresHealth Insurance Portability and Accountability ActHealth PersonnelHealth Services AccessibilityHealth systemHealthcareHealthcare SystemsIndividualIndustryInpatientsInsurance CarriersLogisticsMeasurementMeasuresMedicalMedicineModelingOutcomePatient-Focused OutcomesPatientsPennsylvaniaPharmacotherapyPhasePovertyProcessProviderRecoveryRegulationReportingResearchResearch DesignResearch Project GrantsResourcesRiskRoleServicesSocial isolationTechnologyTestingTimeTrainingTransportationTreatment EffectivenessUnited States National Institutes of HealthUniversitiesUrsidae FamilyVisitVulnerable PopulationsWheelchairsaddictionbarrier to carebasebehavioral healthcohortdesigndigitaldrug use screeningfood insecurityhealth care availabilityhealth care service organizationhigh riskinnovationmedical appointmentmedication-assisted treatmentopioid useopioid use disorderoutpatient programspatient engagementpatient populationphase 2 studypopulation healthprogramsracial discriminationrecruitscreeningsocial determinantssocial health determinantssuccesstreatment programwillingness
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Roundtrip’s transportation software platform is a turnkey solution that addresses transportation as a social
determinant of health by offering a single touchpoint for any healthcare organization to coordinate all levels of
non-emergency transportation (rideshare, medical sedan, wheelchair van, non-emergency ambulance) for
specialized patient populations. Given the increasingly strong correlation between transportation, lack of
healthcare access, and patient no-shows to medical care, this project aims to study the effect of providing
subsidized rides for patients afflicted by opioid use disorder (OUD) or drug use that screen positive for a
transportation need. Roundtrip is focused on removing transportation as a barrier to access care, especially
as it pertains to substance and drug use. Roundtrip is currently partnered with some of the most reputed
national healthcare brands in the US across 20 states, including Geisinger, Johns Hopkins, the NIH, and
large behavioral health systems like Aurora Behavioral, moving patients daily that need various forms of
medical care including drug addiction and associated behavioral health issues related to opioid use. This
project seeks to measure the impact of access to timely transportation on overall clinical outcomes for the
aforementioned group of pre-identified patients, allowing partnered healthcare providers to effectively
administer medical care and prescribe medication-assisted treatment to those in need. We will determine if
the Roundtrip platform is an appropriate, scalable mechanism to promote an increased adoption of drug
treatment programs that have had well-documented success in reducing overall drug use by alleviating the
burden of transportation and the associated logistical challenges of such programs. Thus, we look to create a
scalable and data-driven mechanism that expands access to medical care for those affected by OUD and/or
drug use, with the goal of demonstrating a viable and replicable model that can be applied in communities
across the country.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
